Please assess the completion status of the following clinical trial:

Trial Title: Study of Epidural Steroid Injection (ESI) Versus Minimally Invasive Lumbar Decompression (Mild®) in Patients With Symptomatic Lumbar Central Canal Stenosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic Lumbar Spinal Stenosis (LSS) primarily caused by dorsal element hypertrophy.~* Prior failure of conservative therapy and ODI Score \>20%.~* Radiologic evidence of LSS (L3-L5), Ligamentum flavum \>2.5mm, confirmed by pre-op MRI and/or CT.~* Central canal cross sectional area ≤ 100 square mm.~* Anterior listhesis ≤ 5.0mm.~* Able to walk at least 10 feet unaided before being limited by pain.~* Available to complete 26 weeks of follow-up.~* A signed Informed Consent Form is obtained from the patient.~* Adults at least 18 years of age.~Exclusion Criteria:~* Prior surgery at intended treatment level.~* History of recent spinal fractures with concurrent pain symptoms.~* Disabling back or leg pain from causes other than LSS (e.g. acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.)~* Significant / symptomatic disc protrusion or osteophyte formation.~* Excessive / symptomatic facet hypertrophy.~* Bleeding disorders and/or current use of anti-coagulants.~* Use of ASA and/or NSAID within 5 days of treatment.~* Pregnant and/or breastfeeding.~* Epidural steroids previously administered (not ESI naive)~* Wound healing pathologies deemed to compromise outcomes, including: diabetes, excessive smoking history, cancer, connective tissue diseases, recent spine radiation and severe COPD.~* Dementia and/or inability to give informed consent.~* Inability of the patient to lie prone for any reason with anesthesia support (e.g. COPD, obesity, etc.).~* On Workman's Compensation or considering litigation associated with back pain.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vertos mild® Minimally-Invasive Lumbar Decompression (Type: ACTIVE_COMPARATOR): Patients in the Vertos mild® treatment group will be treated by appropriately trained physicians in accordance with the product labeling and indications for use.
- Epidural Steroid Injection (Type: ACTIVE_COMPARATOR): Patients in the Epidural Steroid Injection (ESI) group will have ESI performed by appropriately trained physicians in accordance with product labeling and indications for use.

Based on this trial design, predict the completion outcome and termination type (if applicable).